methods of treating neurological inflammatory disease or seizures caused by neuroinflammation by administering cpmp are described . treating neuroinflammatory and neurometabolic diseases with cpmp is described so as to override dyshomeostasis in the moco synthesis pathway and control synaptic inhibition in the gephyrin - gabar pathway . this is a novel strategy for preventing neural circuit dyshomeostasis by stabilizing inhibitory synapses .